A new trading day began on Monday, with Olema Pharmaceuticals Inc (NASDAQ: OLMA) stock price down -7.79% from the previous day of trading, before settling in for the closing price of $4.62. OLMA’s price has ranged from $2.86 to $16.62 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -83.00% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 14.44%. With a float of $52.12 million, this company’s outstanding shares have now reached $68.33 million.
In an organization with 96 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Olema Pharmaceuticals Inc (OLMA) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Olema Pharmaceuticals Inc is 23.83%, while institutional ownership is 78.66%. The most recent insider transaction that took place on Jan 08 ’25, was worth 1,727,370. In this transaction 10% Owner of this company bought 300,000 shares at a rate of $5.76, taking the stock ownership to the 7,800,000 shares. Before that another transaction happened on Dec 17 ’24, when Company’s Director sold 700,761 for $6.75, making the entire transaction worth $4,730,137. This insider now owns 0 shares in total.
Olema Pharmaceuticals Inc (OLMA) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 14.44% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.25% during the next five years compared to -83.00% drop over the previous five years of trading.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Trading Performance Indicators
Here are Olema Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 15.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.95, a number that is poised to hit -0.43 in the next quarter and is forecasted to reach -2.18 in one year’s time.
Technical Analysis of Olema Pharmaceuticals Inc (OLMA)
Let’s dig in a bit further. During the last 5-days, its volume was 1.43 million. That was better than the volume of 0.99 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 64.55%.
During the past 100 days, Olema Pharmaceuticals Inc’s (OLMA) raw stochastic average was set at 36.44%, which indicates a significant decrease from 40.66% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 70.00% in the past 14 days, which was lower than the 78.68% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.68, while its 200-day Moving Average is $6.97. However, in the short run, Olema Pharmaceuticals Inc’s stock first resistance to watch stands at $4.58. Second resistance stands at $4.89. The third major resistance level sits at $5.06. If the price goes on to break the first support level at $4.10, it is likely to go to the next support level at $3.93. Assuming the price breaks the second support level, the third support level stands at $3.62.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Key Stats
With a market capitalization of 291.47 million, the company has a total of 68,421K Shares Outstanding. Currently, annual sales are 0 K while annual income is -129,470 K. The company’s previous quarter sales were 0 K while its latest quarter income was -30,390 K.
